Methods and formulations of using A1 adenosine and P2X purinoreceptor antagonists

Details for Australian Patent Application No. 2003268839 (hide)

Owner Endacea Inc.

Inventors Wilson, Constance Neely

Agent Pizzeys

Pub. Number AU-A-2003268839

Parent 2002309961

Filing date 15 December 2003

Wipo publication date 22 January 2004

International Classifications

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

22 January 2004 Application Open to Public Inspection

  Published as AU-A-2003268839

22 January 2004 Complete Application Filed

8 December 2005 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003268840-Communication system

2003268838-Gene encoding protein having aurone synthesizing activity